retatrutide vs orforglipron Zepbound: Which Is Better? Retatrutide vs Foundayo (Orforglipron): Injection

The Surging Popularity of GLP-1s By 2024, approximately 4% of Americans were taking a GLP-1 receptor agonist for weight loss, obesity, or type 2 diabetesa staggering 600% increase since 2018

Increasing medication prescribing in primary care offices and settings could help increase access, Gregory said, but there is still a lot of work to be done in figuring out how to reduce these barriers to care and how to best deliver treatment in the most cost-effective, safe and effective ways

A 2025 systematic review mapped weight change after stopping anti-obesity medicines across 11 RCTs

At this temperature, the kinetic energy of molecules is drastically reduced, effectively halting most degradation pathways like oxidation and deamidation